购物车
您的购物车当前为空
RI-AG03是口服活性且能够穿过血脑屏障的Tau聚集肽抑制剂。RI-AG03能够在体内外模型中阻止Tau聚集,并改善相关神经退行性和行为表型,适用于阿尔茨海默症等Tau蛋白病的研究。
RI-AG03是口服活性且能够穿过血脑屏障的Tau聚集肽抑制剂。RI-AG03能够在体内外模型中阻止Tau聚集,并改善相关神经退行性和行为表型,适用于阿尔茨海默症等Tau蛋白病的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
| 产品描述 | RI-AG03 is an orally active peptide inhibitor capable of crossing the blood-brain barrier, targeting Tau aggregation. It effectively inhibits Tau aggregation in both in vivo and in vitro models, improving associated neurodegenerative and behavioral phenotypes. RI-AG03 is applicable in research on Tauopathies such as Alzheimer's disease. |
| 分子量 | 2477.93 |
| 分子式 | C104H189N49O22 |
| Sequence | Ac-{d-Arg}-{d-Arg}-{d-Arg}-{d-Arg}-{d-Arg}-{d-Arg}-{d-Arg}-{d-Arg}-Gly-{d-Pro}-{d-Lys}-{d-Tyr}-{d-Lys<Ac>}-{D-Ile}-{d-Gln}-{d-Val}-Gly-{d-Arg}-NH2 |
| Sequence Short | {d-Arg}-{d-Arg}-{d-Arg}-{d-Arg}-{d-Arg}-{d-Arg}-{d-Arg}-{d-Arg}-G-{d-Pro}-{d-Lys}-{d-Tyr}-{d-Lys<Ac>}-{D-Ile}-{d-Gln}-{d-Val}-G-{d-Arg} |
| 存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
对于不同动物的给药剂量换算,您也可以参考 更多